Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127845481 | 12784548 | 1 | I | 20160827 | 20160927 | 20160927 | EXP | PHHY2016JP118343 | SANDOZ | FUNATSU Y, HIRAYAMA M, SHIRAISHI J, ASAKURA T, WAKAKI M, YAMADA1 E ET AL.. INTIMAL SARCOMA OF THE PULMONARY ARTERY TREATED WITH PAZOPANIB. INTERNAL MEDICINE. 2016;55(16):2197-202 | 71.00 | YR | M | Y | 0.00000 | 20160927 | OT | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127845481 | 12784548 | 1 | SS | PAZOPANIB | PAZOPANIB | 1 | Unknown | 800 MG, QD | D | 0 | 800 | MG | QD | ||||||
| 127845481 | 12784548 | 2 | SS | IFOSFAMIDE. | IFOSFAMIDE | 1 | Unknown | 2.5 G/M2, (ON DAYS 1-4) EVERY 3 WEEKS | D | 0 | |||||||||
| 127845481 | 12784548 | 3 | PS | DOXORUBICIN | DOXORUBICIN | 1 | Unknown | 25 MG/M2, (ON DAYS 1-3) EVERY 3 WEEKS | D | 200146 | 25 | MG/M**2 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127845481 | 12784548 | 1 | Vascular neoplasm |
| 127845481 | 12784548 | 2 | Vascular neoplasm |
| 127845481 | 12784548 | 3 | Vascular neoplasm |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127845481 | 12784548 | OT |
| 127845481 | 12784548 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127845481 | 12784548 | Blister | |
| 127845481 | 12784548 | Disease progression | |
| 127845481 | 12784548 | Fatigue | |
| 127845481 | 12784548 | Gait disturbance | |
| 127845481 | 12784548 | Neoplasm progression | |
| 127845481 | 12784548 | Neutropenia | |
| 127845481 | 12784548 | Palmar-plantar erythrodysaesthesia syndrome | |
| 127845481 | 12784548 | Therapeutic response decreased | |
| 127845481 | 12784548 | Vascular neoplasm |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |